STERIS said revenues for the 3 months ended September 30, 2025 were $1,460.3 million, up 9.9% from $1,328.9 million in the same prior year period. The company said organic growth in all 3 segments reflected the benefits of higher volume and pricing.

1. 01

   STERIS said revenues for the 3 months ended September 30, 2025 were $1,460.3 million, up 9.9% from $1,328.9 million in the same prior year period. The company said organic growth in all 3 segments reflected the benefits of higher volume and pricing.

2. 02

   STERIS said gross profit percentage for Q2 of fiscal 2026 was 44.2% compared to 43.6% in the same period of the prior year. Impacts from pricing (120 basis points), productivity (90 basis points), and other factors were offset by impacts from inflation (100 basis points), tariff costs (90 basis points), and other factors.

3. 03

   STERIS said net cash provided by operating activities for the first 6 months of fiscal 2026 was $707.8 million, compared to $554.5 million in the same prior year period, and free cash flow was $527.7 million, compared to $344.5 million in the same prior year period. The company cited an increase in earnings and working capital improvements as factors.

4. 04

   STERIS said that during the first 6 months of fiscal 2026, it repaid Private Placement Senior Notes of $125.0 million, paid cash dividends of $118.1 million ($1.20 per share), and repurchased 0.4 million shares for $100.0 million. The company said debt-to-total capital ratio as of September 30, 2025 was 21.3%, compared to 25.3% in the same prior year period.

Key figures

Quarter ended September 30, 2025

Revenue

$1.5B

Operating income

$266M

Net income

$192M

EPS

$1.94

Gross profit

$646M

Analysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.